Some factors affecting a commercial kit for radioimmunoassay of digoxin using tritiated digoxin. 1977

A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas

Some factors affecting results of digoxin determinations using one commercially available radioimmunoassay kit are described and discussed. Serum of pregnant women, cord blood, amniotic fluid and serum of patients taking spironolactone may show erroneously high digoxin activity due to lack of specificity of the antiserum. Cross-reaction with digitoxin was found to vary substantially with antibody-lot. Haemaccel (5 g/1) in the sample leads to too low results. When ethanol (100 g/1) is present results are too high. The need for testing the specifity of every new lot of antiserum before use is stressed.

UI MeSH Term Description Entries
D008297 Male Males
D011097 Polygeline A 3.5 per cent colloidal solution containing urea-cross-linked polymerized peptides. It has a molecular weight of approximately 35,000 and is prepared from gelatin and electrolytes. The polymeric solution is used as a plasma expander. Gelofusine,Haemaccel,Thomaegelin,Gelofusines,Haemaccels,Polygelines,Thomaegelins
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004074 Digitoxin A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665) Coramedan,Digimed,Digimerck,Digitaline Nativelle,Digitoxin AWD,Digitoxin Bürger,Digitoxin Didier,Digitoxin-Philo,Digophton,AWD, Digitoxin,Bürger, Digitoxin,Didier, Digitoxin,Digitoxin Philo,Nativelle, Digitaline
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods

Related Publications

A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
March 1978, Clinical chemistry,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
June 1972, Clinical chemistry,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
January 1977, Horumon to rinsho. Clinical endocrinology,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
August 1981, The Journal of pharmacology and experimental therapeutics,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
March 1981, Radioisotopes,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
May 1985, Radioisotopes,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
June 1975, Clinica chimica acta; international journal of clinical chemistry,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
December 1974, Clinical biochemistry,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
July 1981, Kaku igaku. The Japanese journal of nuclear medicine,
A B Boink, and H H Kruyswijk, and A F Willebrands, and A H Maas
June 1977, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!